Table 1 Demographic and clinical features of the study patients

ReA (n = 5)

2.4 (1 to 6)

32.4 (20 to 50)

4:1

   1

22

M

Sexually acquired ReA; Ct IgG positive^a, Ct IgA positive serology^b

   2

40

F

Sexually acquired ReA;

   3

20

M

Sexually acquired ReA; Ct IgG positive serology^a; Ct IgA positive serology^b; B27+^d

   4

50

M

Sexually acquired ReA; Ct IgA positive serology^b; Ct positive PCR^c; B27+^d

   5

30

M

Sexually acquired ReA

UA (n = 9)

25 (2 to 60)

40 (22 to 59)

5:4

-

RA (n = 7)

66 (12 to 228)

44 (39 to 53)

2:5

-

OA (n = 6)

14 (12 to 24)

58 (44 to 70)

5:1

-